Dergiler / Turkish Journal of Pediatrics / 2020 / Cilt: 62 - Sayı: 1

Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease

Sayfa
1–9
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This may be useful for choosing optimal treatment for KD to prevent coronary artery involvement.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Kawasaki disease (KD) is the most common cause of childhood coronary artery disease.
📊
Temel Bulgular & Veri:Clinical, laboratory and echocardiographic data were retrospectively analyzed in 94 Kawasaki patients.
💡
Sonuç & Katkı:This may be useful for choosing optimal treatment for KD to prevent coronary artery involvement.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Kawasaki disease (KD) is the most common cause of childhood coronary artery disease. The incidence of coronary artery lesions (CALs) has declined with the routine use of intravenous immunoglobulin (IVIG) treatment, but there is still considerable risk for resistance to IVIG treatment and development of CALs. The present study was aimed to determine the risk factors in Turkish children with IVIG resistant KD and coronary artery involvement. Clinical, laboratory and echocardiographic data were retrospectively analyzed in 94 Kawasaki patients. IVIG resistant and responsive groups were compared. The IVIG resistant group had a higher rate of CALs compared to the IVIG responsive group (p<0.05). Duration of fever ≥ 9.5 days, C-reactive protein (CRP) ≥ 88 mg/L and Neutrophil/lymphocyte ratio (NLR) ≥1.69 were the best cutoff values for predicting IVIG resistance before treatment. The criteria for at least two of these three predictors were considered to be statistically significant risk factors for detecting IVIG resistance in KD before treatment (76.47% sensitivity, 71.05% specificity and 95% CI were 50.1-93.19% and 59.51-80.89%, respectively). Based on the clinical and laboratory features, we established a new risk-scoring system for predicting IVIG resistance in a cohort of Turkish children with KD. This may be useful for choosing optimal treatment for KD to prevent coronary artery involvement.

🔖

Bu Makaleye Atıf Yap

TÜRKUÇAR, S., YILDIZ, K., ACARI, C., DUNDAR, H. A., KIR, M. Ç., ÜNSAL, E. (2020). Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. Turkish Journal of Pediatrics, Cilt: 62 - Sayı: 1, 1–9. https://ajindex.com/articles/411825

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (17)

  1. McCrindle BW, Rowley AH, Newburger JW, et al. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young
  2. Council on Cardiovascular and Stroke Nursing
  3. Council on Cardiovascular Surgery and Anesthesia
  4. and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation 2017
  5. e927-e999. 2.Hara T, Nakashima Y, Sakai Y, Nishio H, Motomura Y, Yamasaki S. Kawasaki disease: a matter of innate immunity. Clin Exp Immunol 2016
  6. Huang YH, Lo MH, Cai XY, Kuo HC. Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease. Oncotarget 2018
  7. 18939-18948. 4.Chen KYH, Messina N, Germano S, et al. Innate immune responses following Kawasaki disease and toxic shock syndrome. PLoS One 2018: e0191830. 5.Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986
  8. Ha KS, Jang GY, Lee J, Lee KC, Son CS. Laboratory markers in incomplete Kawasaki disease according to coronary artery outcome. Korean Circ J 2018
  9. Ozen S, Bakkaloglu A, Dusunsel R, et al
  10. Turkish Pediatric Vasculitis Study Group Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol 2007
  11. Kayiran SM, Dindar A, Gurakan B. An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study. Clinics (Sao Paulo) 2010
  12. Ozdemir H, Ciftçi E, Tapisiz A, et al. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey. J Trop Pediatr 2010
  13. Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 2006
  14. Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006
  15. Sano T, Kurotobi S, Matsuzaki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 2007
  16. Sleeper LA, Minich LL, McCrindle BM, et al
  17. Pediatric Heart Network Investigators. Evaluation of Kawasaki disease risk-scoring systems for intraveno